Home / Stocks / ALGN

Align Technology (ALGN, Health Care Supplies) Stock Valuation & Fair Value Quality business with a solid forward outlook

Align Technology (ALGN, Health Care Supplies) trades at a blended P/E of 14.5, about 64% below its historical normal valuation, with a forward growth estimate of 10.3% and a PEG of 1.40. Analysts' one-year estimates have been hit 36% of the time.

DATA AS OF 2026-08-21
Blended P/E
14.5
Normal P/E
39.7
PEG
1.40
Fwd growth
10.3%
Div yield
0.0%
RSI (14)
44.3
Neutral

The Street vs SeerForecast

Wall Street's mean price target for ALGN is $208.60 across 15 analysts, 28.3% above the current price. The average analyst rating is Buy. Our SeerForecast read of the same stock, formed without analyst targets: quality business with a solid forward outlook. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from fairly valued (2026-06-03) to quality business with a solid forward outlook (2026-08-21).

Price and rating by weekClose moved +12.1 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 161.71 (recalculated)2026-06-10: Fairly valued, close 170.50 (recalculated)2026-06-14: Fairly valued, close 174.84 (recalculated)2026-06-16: Fairly valued, close 179.52 (recalculated)2026-06-21: Fairly valued, close 182.08 (recalculated)2026-07-02: Fairly valued, close 184.52 (recalculated)2026-07-06: Fairly valued, close 188.39 (recalculated)2026-07-09: Fairly valued, close 178.17 (recalculated)2026-07-12: Fairly valued, close 179.45 (recalculated)2026-07-13: Fairly valued, close 180.59 (recalculated)2026-07-14: Fairly valued, close 178.46 (recalculated)2026-07-20: Fairly valued, close 175.05 (recalculated)2026-07-22: Fairly valued, close 172.46 (recalculated)2026-07-25: Fairly valued, close 167.02 (recalculated)2026-07-27: Fairly valued, close 168.05 (recalculated)2026-07-31: Fairly valued, close 169.16 (recalculated)2026-08-03: Fairly valued, close 169.162026-08-07: Fairly valued, close 173.66 (recalculated)2026-08-10: Fairly valued, close 173.662026-08-14: Fairly valued, close 181.31 (recalculated)2026-08-17: Fairly valued, close 181.311621812026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 16.0-60%Fairly valued
2026-06-10P/E 15.4-61%Fairly valued
2026-06-14P/E 15.4-61%Fairly valued
2026-06-16P/E 15.4-61%Fairly valued
2026-06-21P/E 15.4-61%Fairly valued
2026-07-02P/E 16.6-58%Fairly valued
2026-07-06P/E 16.9-57%Fairly valued
2026-07-09P/E 16.9-57%Fairly valued
2026-07-12P/E 16.4-59%Fairly valued
2026-07-13P/E 16.4-59%Fairly valued
2026-07-14P/E 16.4-59%Fairly valued
2026-07-20P/E 16.1-59%Fairly valued
2026-07-22P/E 16.1-59%Fairly valued
2026-07-25P/E 15.2-62%Fairly valued
2026-07-27P/E 15.2-62%Fairly valued
2026-07-31P/E 15.8-60%Fairly valued
2026-08-03P/E 15.5-61%Fairly valued
2026-08-07P/E 15.4-61%Fairly valued
2026-08-10P/E 15.8-60%Fairly valued
2026-08-14P/E 16.1-60%Fairly valued
2026-08-17P/E 16.5-58%Fairly valued
2026-08-21P/E 14.5-64%Quality business with a solid forward outlook ← now

Frequently asked questions

Is Align Technology stock overvalued?

At a blended P/E of 14.5 versus its historical normal P/E of 39.7, Align Technology trades about 64% below its typical valuation, with a PEG of 1.40 on 10.3% forward growth. tickerseer currently rates it quality business with a solid forward outlook.

What is Align Technology's fair value and PEG?

Align Technology trades at a blended P/E of 14.5 against a historical normal P/E of 39.7, a PEG of 1.40, and a forward growth estimate of 10.3%.

Has tickerseer's rating of Align Technology changed?

tickerseer's rating moved from fairly valued (2026-06-03) to quality business with a solid forward outlook (2026-08-21).

What is the analyst price target for Align Technology?

The mean Wall Street price target for Align Technology is $208.60 across 15 analysts, 28.3% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track ALGN free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.